Barbara Kosacz - Net Worth and Insider Trading

Barbara Kosacz Net Worth

The estimated net worth of Barbara Kosacz is at least $1 Million dollars as of 2024-04-13. Barbara Kosacz is the COO & General Counsel of Kronos Bio Inc and owns about 928,966 shares of Kronos Bio Inc (KRON) stock worth over $1 Million. Details can be seen in Barbara Kosacz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barbara Kosacz has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).

Transaction Summary of Barbara Kosacz


Barbara Kosacz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barbara Kosacz owns 6 companies in total, including Kronos Bio Inc () , XOMA Corp () , and XOMA Corp () among others .

Click here to see the complete history of Barbara Kosacz’s form 4 insider trades.

Insider Ownership Summary of Barbara Kosacz

Ticker Comapny Transaction Date Type of Owner
Kronos Bio Inc 2024-01-04 COO & General Counsel
XOMA Corp 2019-01-01 director
XOMA Corp 2019-01-01 director
Athira Pharma Inc 2021-03-04 director
eFFECTOR Therapeutics Inc 2021-01-07 director
Phoenix Biotech Acquisition Corp 2021-10-05 director

Barbara Kosacz Latest Holdings Summary

Barbara Kosacz currently owns a total of 1 stock. Barbara Kosacz owns 928,966 shares of Kronos Bio Inc (KRON) as of January 4, 2024, with a value of $1 Million.

Latest Holdings of Barbara Kosacz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRON Kronos Bio Inc 2024-01-04 928,966 1.13 1,049,732

Holding Weightings of Barbara Kosacz

Barbara Kosacz Form 4 Trading Tracker

According to the SEC Form 4 filings, Barbara Kosacz has made a total of 2 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Kronos Bio Inc is the sale of 10,676 shares on January 4, 2024, which brought Barbara Kosacz around $12,598.

Insider Trading History of Barbara Kosacz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Barbara Kosacz Trading Performance

GuruFocus tracks the stock performance after each of Barbara Kosacz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barbara Kosacz is 1.24%. GuruFocus also compares Barbara Kosacz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barbara Kosacz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Barbara Kosacz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Barbara Kosacz

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -11.66 1.24 -30.28 -47.99 -70.01 -68.47
Relative Return to S&P 500(%) -14.43 -7.56 -48.51 -75.21 -71.35 -75.93

Barbara Kosacz Ownership Network

Ownership Network List of Barbara Kosacz

No Data

Ownership Network Relation of Barbara Kosacz

Barbara Kosacz Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Barbara Kosacz is the COO & General Counsel of Kronos Bio Inc. Other key executives at Kronos Bio Inc include Chief Scientific Officer Christopher Dinsmore , Chief Medical Officer & VP Jorge Dimartino , and director & 10 percent owner & President & CEO Norbert W Bischofberger .

Kronos Bio Inc () Insider Trades Summary

Over the past 18 months, Barbara Kosacz made 1 insider transaction in Kronos Bio Inc () with a net sale of 10,676. Other recent insider transactions involving Kronos Bio Inc () include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .

In summary, during the past 3 months, insiders sold 31,509 shares of Kronos Bio Inc () in total and bought 0 shares, with a net sale of 31,509 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc () were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.

Kronos Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.


Kronos Bio Inc Insider Transactions

No Available Data

Barbara Kosacz Mailing Address

Above is the net worth, insider trading, and ownership report for Barbara Kosacz. You might contact Barbara Kosacz via mailing address: 3175 Hanover Street, Palo Alto Ca 94304.

Discussions on Barbara Kosacz

No discussions yet.